[Prevention of tachycardia induced by a fentanyl-pancuronium combination in the coronary patient: propranolol or verapamil?].
Magnin
C
C
Département d'Anesthesiologie, Hôpital Cantonal Universitaire de Geneve, Suisse.
Neidhart
P
P
D003327:Coronary Disease / Q000150:complications* / Q000503:physiopathology; D005283:Fentanyl / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D010197:Pancuronium / Q000009:adverse effects*; D011433:Propranolol / Q000627:therapeutic use*; D013610:Tachycardia / Q000139:chemically induced / Q000517:prevention & control*; D014700:Verapamil / Q000627:therapeutic use*
D011433:Propranolol; D014700:Verapamil; D010197:Pancuronium; D005283:Fentanyl
Prévention de la tachycardie induite par l'association fentanyl-pancuronium chez le patient coronarien: propranolol ou vérapamil?